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Objectives. We sought o assess the ability of the "biphasic" 
response (i.e., initial improvement in wall thickening followed by 
reduced wall thickening) during serial dobutamine stress echo- 
cardiography to detect ischemia in patients with a wall motion 
abnormality. Furthermore, we compared the power of the biphasic 
echocardiographic response with that of myocardial perfusion 
imaging for the detection of myocardial ischemia. 
Background. Stress echocardiography as been shown to be 
less sensitive than radionuclide perfusion imaging for detecting 
ischemia in patients with a wall motion abnormality. Peak stress 
wall thickening in such areas may not give a full account of the 
intermediate changes, whereas initial improvement (the biphasic 
response) may enhance diagnosis. 
Methods. Patients with a wall motion abnormality and docu- 
mented coronary arteff disease underwent simultaneous graded 
dobutamine (5 to 40/~g/kg body weight per min) stress echocar- 
diography and radionuclide perfusion imaging with single-photon 
emission computed tomography using either technetium-99m 
sestamibi or technetium-99m tetrofosmin. Semiquantitative anal- 
yses of image groups were performed in blinded manner by two 
separate groups of observers. 
Results. Myocardial ischemia was detected by perfusion imag- 
ing in 45 of the 54 patients. High dose dobutamine echocardiog- 
raphy detected ischemia in only 25 (56%) of these patients. 
However, when the biphasic response was taken into account, 
ischemia was detected in 44 (98%) of the 45 patients (p < 0.001). 
Agreement between radionuclide imaging and echocardiographic 
findings for the detection of ischemia was significantly enhanced 
(p = 0.03) when the biphasic response was used (89%, kappa = 
0.51) instead of high dose stress dobutamine chocardiography 
(56%, kappa = 0.10). 
Conclusions. The detection of myocardial ischemia may be 
significantly enhanced by utilizing the biphasic response during 
serial stress dobutamine echocardiography in patients with a wall 
motion abnormality. 
(J Am Coil Cardiol 1995;26:26-32) 
It is well known (1,2) that stress echocardiography, despite its 
extensive use, does not identify' regions of reversible myocar- 
dial ischemia in left ventricular segments in which a wall 
motion abnormality is present at rest. Previous tudies (3-5) 
have shown that radionuclide perfusion imaging is superior to 
stress cchocardiography for detecting reversible ischemia in 
such patients. 
Recent studies (6-8) have shown that dobutamine cho- 
cardiography may be used to detect regional myocardial via- 
bility by utilizing a low dose of dobutamine (5to 10/xg/kg body 
weight per rain) that provokes improved left ventricular wall 
thickening in regions presenting with left ventricular dysynergy 
at rest. Pierard et al. (9) demonstrated that, in patients with 
myocardial infarction with regional asynchrony, wall thicken- 
ing initially improves with administration of low dose dobut- 
From the Department ofCardiology, North~ick Parkito-apital ndlnstituic 
of Medical Research, Harrow, England, Umtcd Kingdom l'his study ;~as iunded 
by an educational grant from the Northwlck Park tto~,pltal Cardiac Research 
Fund, Harrow. 
Manuscript received Scptembcl 14, 1994. rcvi,~cd manuscript rcccixcd 
February l, 1995, accepted March 1. 1995 
Address for correspondence: Dr AvljLt Lahtri. Department of Cardiology, 
Northwick Park Hospital. Warlord Road, I-tarmac, Middlesex HA1 3U J, England 
United Kingdom 
amine then deteriorates with administration of high dose 
dobutamine (15 to 40/xg/kg per min). This "biphasic" response 
correlated with residual coronary artery stenosis in that region 
and was thought o be indicative of myocardial ischemia. 
We hypothesized that this biphasic echocardiographic re-
sponse to dobutamine infusion may be utilized in a wider range 
of patients with stable coronary heart disease who present with 
a regional wall motion abnormality at rest. Thus, we selected 
patients with documented ischemic heart disease and a re- 
gional wall motion abnormality of the left ventricle who had 
undergone simultaneous dobutamine chocardiography and 
myocardial perfusion imaging. We used both technetium 
(Tc)-99m sestamibi (10-12) and Tc-99m tetrofosmin (13-15) 
as a marker of myocardial ischemia in the radionuclide studies. 
Changes in regional wall thickening during dobutamine 
infusion were compared with the results of myocardial perfu- 
sion imaging to determine the accuracy of dobutamine echo- 
cardiography in detecting myocardial ischemia in myocardial 
regions presenting with abnormal wall motion. 
Methods  
Patient selection. Fifty-four patients who underwent con- 
trast angiography for the diagnosis or management of coronary 
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heart disease and were found to have a wall motion abnormal- 
ity were evaluated by echocardiography. Patients who were 
echogenic and whose wall motion abnormality was confirmed 
by echocardiography were then further evaluated. We ex- 
cluded from the study patients with acute myocardial infarc- 
tion within 8 weeks, unstable angina, severe heart failure, 
significant valvular heart disease, cardiomyopathy, severe hyper- 
tension (systolic and diastolic blood pressure >200/120 mm Hg, 
respectively) or left bundle branch block. Those taking beta- 
adrenergic blocking agents or a calcium antagonist, orboth, were 
asked to gradually stop their medications for at least 48 h before 
the imaging protocol whenever possible. All other cardioactive 
drugs, including short-acting nitrates, were stopped 24 h beforc 
the imaging protocol. The study was approved by the hospital's 
thics committee. 
Study design. Baseline echocardiography was performed 
and followed by a graded infusion of dobutamine. Echocardi- 
ography was repeated at the end of each stage of infusion of 
dobutamine and also at the peak dose. At the peak dose, either 
Tc-99m sestamibi or Tc-99m tetrofosmin was injected and the 
dobutamine infusion was continued for 1 additional minute 
whenever possible. Echocardiography was repeated 10 rain 
into the recovery period. Scintigraphic images after dohut- 
amine stress were then obtained (at 1 to 2 h for sestamibi and 
within 15 to 45 min for tetrofosmin). Rest scintigraphic mages 
were obtained on a separate day by using the same dose of 
sestamibi or tetrofosmin within 3 to 7 days of the stress test. 
Dobutamine stress. After a baseline electrocardiogram 
and echocardiogram were obtained, dobutamine was infused 
through aperipheral intravenous line with a mechanical pump, 
starting at a dose of 5 gg/kg per rain. The dose was increased 
by 5 p,g/kg per rain every 3 rain. End points of the test were the 
achievement of peak dose (40 p,g/kg per rain), development of 
severe ischemia (increasing angina, extensive wall motion 
abnormality, >3-ram ST segment shift) or the occurrence of 
intolerable side effects. The latter included severe palpitation, 
dyspnea, significant arrhythmia, severe hypertension or hypo- 
tension (>30-ram Hg decrease in systolic pressure). The 
radioactive tracer was injected 1 rain before termination of the 
dobutamine infusion. 
Myocardial peffusion imaging. Scintigraphic data were 
obtained 60 to 120 rain after the injection of 600 MBq of 
Tc-99m sestamibi or within 15 to 45 rain of 400 MBq of Tc-99m 
tetrofosmin administration. Imaging was performed with a 
large field of view gamma camera equipped with a high 
resolution collimator (Sohpy DST, Cedex, France). Thirty-two 
projections (20 s/projection) were acquired over a 180 ° semi- 
circular arc, from the 45 ° right anterior oblique to the 45 ° left 
posterior oblique position. For the purposes of visual interpre- 
tation the single-photon emission computed tomographic 
(SPECT) images were transformed into a polar map with 18 
segments and the stress and rest images were read simulta- 
neously. This method of transformation has been described 
previously (10). The apex was represented in the center, the 
septum to the left, the lateral wall to the right and the anterior 
and inferior walls above and below, respectively. These images 
were read by two experienced observers who did not know the 
clinical, echocardiographic or angiographic characteristics of 
the patient. Perfusion images during stress and at rest were 
qualitatively compared by segment. Regions were then inter- 
preted as normal, ischemic (stress-induced perfusion defect), 
mixed (fixed defect with partial fill-in at rest compared to 
stress) and fixed perfusion defect. The patient was considered 
to have myocardial ischemia if the segments howed either 
ischemic or mixed responses. 
Echocardiography. Echocardiography was performed with 
an Ultramark 9 (Advanced Technology Laboratories) ystem 
with the use of a 2.25-MHz transducer in the parasternal long- 
and short-axis and apical four- and two-chamber views. Images 
were digitized on-line with an R wave trigger to obtain a 
continuous loop, quad-screen display with the Prevue and 
Image-View (Nova Microsonic) systems. Images were stored 
on VHS videotape, on 5.25 in. (13.34-cm) floppy disks and 
optical disks. 
The echocardiographic images were evaluated from the 
digitized quad-screen display and also from the videotape 
playback by two experienced observers who were unaware of 
the results of the nuclear imaging. Differences in interpretation 
were resolved by consensus. For wall motion analysis the left 
ventricle was divided into 11 segments (16). Echocardiograms 
were read at rest, during low dose dobutamine administration, 
at peak dobutamine dose and during recovery. Segments were 
analyzed for systolic wall thickening and endocardial wall 
motion and wcre graded from 1 to 5 (normal -- 1, mild 
hypokinesia -- 2, severe hypokinesia = 3, akinesia = 4 and 
dyskinesia -- 5). Results of dobutamine chocardiography 
were considered normal if all segments judged normal at 
baseline showed a normal hyperdynamic response with in- 
creascd systolic wall thickening. The development of new or 
worscning regional dyssynergy during dobutamine stress was 
considered to indicate ischemia. Initial improvement by one 
gradc in regions with left ventricular dyssynergy at rest during 
low dose dobutamine stress, with subsequent worsening at 
peak dose, was considered a mixed or biphasic response. No 
change in basal asynergy throughout dobutamine infusion was 
considered to be due to infarction or a fixed defect. The patient 
was considered to have reversible myocardial ischemia if the 
response was ischemic or biphasic (mixed). The radionuclide 
and echocardiographic methods utilized in this study have 
been validated and described in detail (12). 
Corona~ arteriography. Coronary arteriography was per- 
formed in all patients in multiple projections with use of the 
Judkins technique. Images were recorded on 35-mm cine film. 
Coronary stenosis was evaluated qualitatively by two indepen- 
dent experienced observers who were unaware of the imaging 
results. Significant coronary artery disease was identified when 
>50% diameter stenosis was present in a major epicardial 
vessel. Collateral circulation was graded visually on a binary 
scale depending on the degree of side branches without 
opacification of the epicardial vessel; a score of 1 was defined 
as partial or complete filling of the occluded vessel through 
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collateral vessels. Only vessels with a score of 1 were consid- 
ered to be supplied by a well developed collateral circulation. 
Analysis, To allow a valid comparison of each technique in 
localizing ischemia the segments from the radionuclide and 
echocardiographic images were grouped into three myocardial 
regions: anteroseptal, inferoposterior and lateral. Because of 
the variability in vascular supply to the apex, this region was 
allocated to any of the involved areas; if the apex alone was 
involved, it was allocated to thc anterior territory (12). To 
avoid the bias of a stress-induced regional wall motion abnor- 
mality affecting adjacent segments in the same patient, analysis 
was performed to reflect comparison of the two techniques in 
individual patients. When a patient had more than one abnor- 
mal region at rest, the stress-induced ischemic response in any 
one region was accepted as abnormal. 
Statistical analysis. All continuous variables are expressed 
as mean value _+ SD. Agreement between the results of 
perfusion imaging and echocardiography was obtained as the 
percent of concordant diagnoses and was also assessed by 
calculating the kappa value. Kappa values between 0.70 and 1 
were considered indicative of good agreement, hose between 
0.40 and 0.69 of moderate agreement and those <0.40 of poor 
agreement. The McNemar test was used to compare the 
percent of concordant diagnoses between paired data. The 
Fleiss test was used to compare kappa values. A p value < 0.05 
was considered significant. 
Resu l ts  
Patients. Fifty-four patients were evaluated; the group 
comprised 50 men and 4 women, with a mean age of 64 years 
(range 45 to 80). Thirty-three patients had documented myo- 
cardial infarction. Twenty-seven patients underwent sestamibi 
SPECT imaging and another 27 patients underwent tetrofos- 
rain SPECT imaging. All 54 patients had significant coronary 
artery disease (9 with one-vessel, 21 with two-vessel and 24 
with three-vessel disease by our criteria). 
Hemodynamic response to dobutamine. With the peak 
dose of dobutamine, the mean _+ SD heart rate was 134 + 23 
Table 1. Hemodynamic Response to Dobutamine Infusion 
Heart Rate SBP Rate-Pressure Product 
(beats/min) (mm Hg) (mm Hg.min) 
Baseline 73 ± 11 108 -_ 14 7,880 _+ 1,847 
Low dose 73 _+ 13 117 ~ 18' 8,489 _+ 2,290 
Peak dose 134 + 23+ 165 - 83T 22,365 + 5,607 
*p < (I.05 versus baseline. ?p < 0.0001 versus low dose dobutamine. Data are 
expressed as mean value _+ SD. SBP = systolic blood pressure. 
beats/min and systolic blood pressure was 165 _ 83 mm Hg; 
these values were significantly higher than those achieved with 
low dose dobutamine (Table 1). The maximal ST segment 
depression was 0.9 _+ 0.5 mm. It was possible to achieve the 
maximal dose of dobutamine in 18 patients. The end point for 
ischemia was evidenced in 30 patients: typical angina in 12, 
9 > l-mm ST segment depression i  9 and deterioration of wall 
thickening in 9. Only six patients did not reach a predeter- 
mined end-point; in this group the infusion was terminated 
because of palpitation, breathlessness or symptomatic hypo- 
tension in two patients each. However, dobutamine infusion 
induced hypotension in eight patients, four with one-vessel 
disease and four with two-vessel disease. Two patients could 
not withdraw from/3-blockers completely, but the dobutamine 
infusion was stopped in both because of the development of 
angina. 
Detection ofischemia. Of a total of 162 myocardial regions 
studied, 68 showed a wall motion abnormality at rest. Forty- 
eight regions were classified as akinetic, 13 as severely hypo- 
kinetic and 7 as mildly hypokinetic. No region was dyskinetic. 
Forty patients had one abnormal region at rest; the other 14 
had two regions of wall motion abnormality. 
For the purpose of this study myocardial ischemia by stress 
perfusion imaging was considered the reference standard. 
Thus, reversible myocardial ischemia was detected by perfu- 
sion imaging in 45 of the 54 patients with a wall motion 
abnormality. These regions were either partially reversible 
(mixed) or totally reversible (ischemic). Nine patients howed 
a fixed defect (Fig. 1). Dobutamine chocardiography revealed 
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Figure 1. Comparison of dobutamine perfusion imaging 
and high and low dose dobutamine chocardiography (Dob 
Echo). Biphasic = biphasic response with deterioration of 
wall thickening at a high dose of dobutamine after initial 
improvement at a low dose; Fixed = fixed perfusion defect. 
Numbers indicate number of patients. 
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Table 2. Diagnosis by Dobutamine Echocardiography in Regions of 
Ischemia As Assessed by Perfusion Imaging in 45 Patients 
Dob Echo (biphasic) 
lschemia Fixed Total 
Dob Echo (high dose) 
Ischemia 25 IJ 25 
Fixed 19 1 2(~ 
Total 44 1 45 
Data are expressed as number of patients. The number of patients classified 
by the biphasic response as showing ischemia (n 44) is significantly higher 
(p < 0.001) than that obtained by the analysis using only high dose dobutamine 
echocardiography (n - 25). Dob Echo - dobutamine chocardiography; 
Fixed - fixed defect. 
an ischemic or biphasic response in 44 (98%) of these 45 
patients, whereas assessment of peak dose echocardiographic 
images detected ischemia in only 25 (56%) of these 45 patients 
(Fig. 1). Thus, the biphasic response detected 19 patients with 
ischemia who were missed by the peak dose echocardiographie 
study (p < 0.001) (Table 2, Fig. 2). 
The agreement between the results of radionuclide imaging 
and dobutamine chocardiography using the biphasic response 
for detection of ischemia was 89% (kappa = 0.51). When the 
results of only the peak dose of dobutamine chocardiography 
were utilized, the agreement with perfusion imaging for detec- 
tion of myocardial ischemia was only 56% (kappa = 0.10) (Fig. 
3). When biphasic and high dose imaging were compared, 
there was a significant difference (p = 0.03) between the two 
methods (Fig. 3). However, of the six patients who were unable 
to achieve the peak dose of dobutamine, three had a reversible 
perfusion defect and three had a fixed defect, but all six had a 
biphasic echocardiographic response. It is unlikely that the 
concordance between biphasic echocardiographic responses 
and perfusion imaging or that between high dose dobutamine 
echocardiography and perfusion imaging would have been 
affected significantly by failure to reach the maximal dose in 
our study. The agreement between the biphasic response for 
ischemia by dobutamine echocardiography and sestamibi 
SPECT imaging was 93% (kappa - 0.63) and that with 
tetrofosmin imaging was 85% (kappa - 0.42). However, there 
DOB ECHO ("biphasic") DOB ECHO (high dose) 
+ 0 + 0 
+ 44 1 + 25 20 
Perfusion Perfusion 
Imaging Imaging 
0 5 4 0 4 5 
Agreement 89% (kappa = 0.51 ) Agreement- 56% (kappa= 0.10) 
Figure 3. Agreement between dobutamine perfusion imaging and 
dobutamine chocardiography for identification of ischemia in 54 
patients. Data are expressed as number of patients. The difference 
between the two kappa values was significant (p = 0.03). Perfusion 
Imaging - technetium (Tc)-99m sestamibi or Tc-99m tetrofosmin 
single-photon emission computed tomography; + = myocardial isch- 
emia: 0 = no ischemia; other abbreviations as in Figure 1. 
was no significant difference between the two groups (p = 0.5) 
(Fig. 4). 
The following data show the comparison between perfusion 
imaging and stress echocardiography using the biphasic re- 
sponse for the detection of reversible ischemia in all regions, 
that is, those with and without a wall motion abnormality. 
Of 162 total regions, perfusion imaging detected 110 
ischemic regions, whereas echocardiography detected 105 
(concordance = 85%; kappa = 0.65). 
The sensitivity for detecting reversible ischemia by perfu- 
sion imaging was 67% and 72% for one-vessel disease, 55% 
Figure 2. Dobutamine chocardiographic images obtained in the 
two-chamber view at end-systole. Left, There is severe hypokinesia of 
the inferior and anterior walls (arrows) before dobutamine infusion 
Middle, There is marked improvement in wall thickening of the 
anterior wall during low dose dobutamine administration. Right, At 
the peak dobutamine dose the anterior wall becomes severely hypoki- 
netic. Thus, the biphasic response in the anterior wall suggests i chemia, 
whereas consideration of only the basal (left) and peak dobutamine 
images (right) suggests that the anterior wall has a fixed defect. 
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Figure 4. Comparison of detection of ischemia by dobut- 
amine echocardiography and technetium-99m sestamibi 
(MIBI) and technetium-99m tetrofosmin single-photon 
emission computed tomography. Data are expressed as 
number of patients. There was no significant difference 
(p = 0.5) between the two kappa values. Other abbrevia- 
tions as m Figure 1. 
Agreement =93% (kappa = 0.63) Agreement - 85% (kappa - 0.42) 
and 60% for two-vessel disease and 29% and 30% for three- 
vessel disease, for detecting >50% and >70% coronary le- 
sions, respectively. The corresponding data on sensitivity for 
detecting reversible wall motion abnormality by stress echo- 
cardiography were 71% and 72% for one-vessel disease, 52% 
and 59% for two-vessel disease and 26% and 29% for three- 
vessel disease. There were no significant differences between 
the two techniques for dctccting reversible ischemia. 
Coronary artery anatomy subtendiJg areas of regional wall 
motion abnormali~. The relation between coronary artery 
disease and the presence or absence of regional ischemia as 
assessed by the two imaging modalities is shown in Table 3. 
Discuss ion  
We used both Tc-99m sestamibi and Tc-99m tetrofosmin to 
increase the power of our observations. Tc-99m sestamibi has 
been widely used for stress dobutamine imaging and has high 
sensitivity and specificity for detecting coronary artery disease 
(10-12). Previous investigators (17) have suggested that it is 
subject to early redistribution in some patients, but this 
characteristic does not seem to affect its overall sensitivity tbr 
detecting coronary artery disease (18). Tc-99m tetrofosmin, 
developed in our laboratory jointly with Amersham Interna- 
tional Plc (Amersham Labs, Amersham, Bucks, England, 
United Kingdom) (19), has now undergone many clinical 
studies (13-15). With this agent there is no evidence of 
redistribution (20), and it clears rapidly from the liver after 
dobutamine infusion (21). Because both radiotracers detect 
reversible myocardial perfusion abnormalities, we compared 
the pooled radionuclide data with the results of the echocar- 
diographic studies. 
Stress echocardiography as gained widespread use for the 
detection of myocardial ischemia nd coronary artery disease 
(1,2,22). Dobutamine stress testing, an alternative mode of 
stress, is used increasingly to elicit myocardial ischemia nd to 
detect significant coronary artery disease in conjunction with 
perfusion imaging and echocardiography (23-25). However, 
there has been considerable debate about the extent o which 
dobutamine chocardiography provides information concor- 
dant with that of perfusion scintigraphy, especially in patients 
with regional wall motion abnormalities at rest (3-5). 
Several studies (1,3-5) have shown that stress echocardiog- 
raphy has low sensitivity for detecting myocardial ischemia in 
myocardial segments with an existing wall motion abnormality. 
Identification of ischemia in areas of dyssynergy is of para- 
mount importance because its presence may suggest hibernat- 
ing myocardium, which is likely to benefit from revasculariza- 
tion (6-8). Low dose dobutamine has been shown to improve 
wall thickening suggestive of myocardial viability in dyssynergic 
Table 3. Coronary Artery. Anatomy Subtending Areas of Wall Motion Abnormality (n - 68 
myocardial regions) 
Coronary Arteries 
Occluded With Occluded With 
Grade 0 Grade 1 >50% Narrowing 
Collateral Vessels Collateral Vessels With Anterograde Flow 
(n 8) (n 28) (n - 32) 
lschcmia Fixed lschemia Fixed Ischemia Fixed Normal 
Perfusion imaging 4 4 23 5 30 0 2 
Biphasic response 3 5 28 0 32 0 0 
on echo 
High dose ischemia 3 5 18 10 15 17 0 
Data are presented a~ number of myocardial regions, echo - dobutamine chocardiography; Fixed - fixed perfusion 
defect. 
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segments after myocardial infarction. However, at high doses 
of dobutamine in these segments subsequent deterioration of
contractility is a sign of myocardial ischemia, and this finding 
correlates with significant residual stenosis in the infarct- 
related artery (9). 
We utilized this biphasic response of dobutamine echocar- 
diography as a marker of ischemia in our 54 patients with a 
regional wall motion abnormality and documented coronary 
artery disease, and we correlated these findings with simulta- 
neous dobutamine s stamibi and tetrofosmin SPECT imaging. 
Perfusion imaging was considered the standard for detection of 
ischemia for the purpose of comparison. When the results of 
dobutamine echocardiography were assessed by using the peak 
dose, ischemia was identified in only 56% of patients. How- 
ever, when they were assessed with the biphasic response, 
there was significant improvement in detection of ischemia to 
98% (p < 0.001). The agreement for detection of ischemia 
between simultaneous myocardial perfusion imaging and echo- 
cardiography using the biphasic response was 89% (kappa 
0.51), which was significantly greater (p = 0.03) than the 
agreement obtained using only the peak dose (56%, kappa 
0.10). 
Pozzoli et al. (5) and Quinones et al. (4) found that the 
agreement between stress echocardiography and perfusion 
scintigraphy for the detection of ischemia was significantly 
lower in patients with than in those without a regional wall 
motion abnormality. Using simultaneous dobutamine echocar- 
diography and sestamibi SPECT imaging, Forster et al. (3) also 
found an agreement of only 66% for detection of ischemia in 
patients with versus 84% in those without a wall motion 
abnormality. In all these studies only the peak stress echocar- 
diographic images were evaluated. When we compared the 
peak dose only, these reports compared well with our data. 
However, we were able to improve detection of myocardial 
ischemia by using the results of the biphasic response during 
dobutamine chocardiography. Furthermore, there was no 
significant difference between the two radionuclide methods 
used. 
In our study five of nine regions diagnosed as showing a 
fixed defect by perfusion imaging were assessed as showing 
ischemia with use of the biphasic response of dobutamine 
eehocardiography. All five regions were subtended by stenotic 
arteries that demonstrated anterograde flow or collateral 
vessels. These data may suggest hat these areas were not 
falsely positive for ischemia, as indicated by perfusion imaging, 
However, there appears to be a synergistic role for echocar- 
diographic and radionuclide studies, and either technique may 
be advantageous in some select populations (12). 
The drawback of treadmill exercise echocardiography is 
that it is difficult o monitor wall thickening changes at a low 
level of exercise, and studies reported so far (1,2,26) have only 
assessed peak dobutamine exercise chocardiography for de- 
tection of myocardial ischemia. This factor has also probably 
resulted in the discrepancy between perfusion scintigraphy and 
echocardiography for identifying myocardial ischemia in pa- 
tients with a regional wall motion abnormality (3-5). Becker et 
al. (27) showed that during atrial pacing, wall thickening may 
be reduced significantly in the absence of ischemia during 
heart rates > 180 beats/min, but the peak heart rate achieved in 
our study was significantly ower than 180 beats/min. We have 
shown clearly that in most cases low dose dobutamine alone 
will uncover viable myocardium in regions with a severe wall 
motion abnormality. However, to a patient referred for routine 
stress testing, the test may need not only to uncover viability, 
but also to show whether inotropic stress wotfld create further 
worsening of already jeopardized myocardium, because these 
data may influence the decision to revascularize. The prognos- 
tic significance of areas that demonstrate mixed defects on 
perfusion seintigraphy and a biphasic response on dobutamine 
echocardiography is uncertain and deserves further investiga- 
tion. In particular, studies have to assess the importance of 
coronary revascularization in these areas. 
In summary, we have examined the value of serial echocar- 
diography during dobutamine stress testing and have clearly 
demonstrated the advantage of the biphasic response for 
enhancing the concordance with the results of radionuclide 
perfusion imaging. 
We acknowlcdge the technical assistance of Usha Raval, the secretarial work of 
Minal Shah and the statistical advice of Caroline Dore, PhD. 
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